Henry Albers
About Henry Albers
Henry Albers, age 36, joined the AeroVironment board in 2025 as a Sponsor Director Nominee following AV’s acquisition of BlueHalo; he currently serves as a Principal at Arlington Capital Partners (ACP). He holds an M.B.A. from Harvard Business School and a B.B.A. in Finance, summa cum laude, from The College of William & Mary, with prior roles at The Carlyle Group (associate) and Morgan Stanley (industrials investment banking analyst) . He is designated an independent director and, as of the 2025 proxy, has no committee assignments or board leadership roles .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Arlington Capital Partners | Principal | 2018–present | Private equity investing in aerospace/defense; board experience across ACP portfolio |
| The Carlyle Group | Associate | Not disclosed | Buyout and strategic minority investments in aerospace/defense |
| Morgan Stanley (Industrials IB) | Analyst | Not disclosed | M&A and capital markets advisory |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Afton Scientific (ACP portfolio) | Director | Current | Private company governance |
| BlueHalo | Director | Current | Defense technology; interlock with AV post-acquisition |
| Forged Solutions Group | Director | Current | Private company governance |
| Grand River Aseptic Manufacturing | Director | Current | Private company governance |
| Qarbon Aerospace | Director | Current | Private company governance |
| Eqlipse Technologies | Former Director | Prior (dates not disclosed) | Private company governance |
Board Governance
| Attribute | Detail |
|---|---|
| Director since | 2025; joined upon BlueHalo closing on May 1, 2025 |
| Independence | Independent (“*” designation) |
| Committee assignments | None as of proxy filing (“—”; “Board Committees and Leadership: None”) |
| Other public boards | 0 |
| Board declassification | Directors elected to one-year terms as board declassifies through 2027 |
| Attendance disclosure | FY2025 board held 11 meetings; all directors (who served in FY2025) attended ≥75%. Albers did not serve during FY2025, so no attendance disclosed for him |
- Sponsor designation rights: ACP V & VI (“Sponsor Members”) can designate two director nominees while owning ≥20% (one nominee if ≥15% and <20%); Albers and Wodlinger are Sponsor Director Nominees .
Fixed Compensation
| Director Responsibilities | Annual Retainer (Cash) |
|---|---|
| Board Members | $60,000 |
| Lead Independent Director | $20,000 |
| Audit Chair | $20,000 |
| Audit Member (non-chair) | $10,000 |
| Nominating & Corporate Governance Chair | $10,000 |
| Nominating & Corporate Governance Member | $5,000 |
| Compensation Chair | $15,000 |
| Compensation Member | $7,000 |
| Cybersecurity Chair | $15,000 |
| Cybersecurity Member | $7,000 |
- Retainers paid quarterly; prorated for partial service; Executive Committee service has no retainer; travel/hospitality for spouses at offsite board meetings (≤$10,000 per director FY2025) .
- Albers and Wodlinger did not serve during FY2025; thus no FY2025 compensation shown for them .
Performance Compensation
| Element | Value | Vesting | Dates/Terms |
|---|---|---|---|
| Annual restricted stock for NEDs (FY2025 policy) | $160,000 grant-date fair value | Time-based; three equal annual installments | FY2025 awards vest July 11, 2025/2026/2027; shares based on closing price at grant |
| New director RS award (FY2025 policy) | $170,000 grant-date fair value | Time-based | Eligible for directors appointed during FY2025 |
| Change-in-control treatment | Accelerated vesting/exercisability of all director equity awards | N/A | Single-trigger acceleration upon completion of a change in control |
- No performance-based (PSU/TSR) metrics disclosed for non-employee directors; director equity is time-based restricted stock .
Other Directorships & Interlocks
| Relationship | Detail | Governance Consideration |
|---|---|---|
| ACP beneficial ownership | ACP-affiliated entities own 12,035,890 shares (24.10% of outstanding as of Aug 7, 2025) | Significant influence; Sponsor Members have board designation rights |
| Sponsor nominees | Albers and Wodlinger designated by ACP under Shareholders Agreement | Potential alignment with ACP interests vs. minority shareholders |
| BlueHalo board seat | Albers serves on BlueHalo’s board; AV acquired BlueHalo on May 1, 2025 | Information flow/interlock; requires clear recusal protocols when subsidiary issues arise |
| Related party transactions | Audit Committee (independent) reviews related party transactions; company disclosed none reportable >$120,000 since May 1, 2024 | Process exists; no reportable transactions mitigates immediate conflict concerns |
Expertise & Qualifications
- Defense industry exposure through 11 years of PE/IB focused on government-regulated aerospace/defense; relevant to AV’s multi-domain systems strategy .
- Board experience across multiple private companies; corporate governance skill-set .
- Advanced finance education (HBS MBA; W&M B.B.A. Finance, summa cum laude) .
Equity Ownership
| Holder | Shares Beneficially Owned | % of Shares Outstanding | As-of Date |
|---|---|---|---|
| Henry Albers | 0 (“—” in table) | 0.00% (49,932,233 shares outstanding) | August 7, 2025 |
- Director stock ownership guidelines: non-employee directors must own ≥5x the annual board cash retainer within 5 years of appointment; 50% of net after-tax vested shares must be held until compliance .
- Anti-hedging/anti-pledging: directors may not hedge AV stock or pledge shares/margin accounts; trades must be pre-cleared .
Governance Assessment
- Independence and committee posture: Albers is listed as independent with no committee roles to date, limiting direct oversight responsibilities but reducing concentration of influence .
- Alignment and incentives: As of Aug 7, 2025 he held 0 AV shares; while within the five-year guideline window, the current lack of ownership is a soft alignment gap until guideline compliance progresses .
- Sponsor influence RED FLAG: ACP’s 24.10% stake and board designation rights—combined with Albers’ ACP role—create potential conflicts of interest and perception risks; robust recusal and Related Party Transaction controls are important mitigants .
- Change-in-control acceleration: Single-trigger acceleration of director equity on change-in-control can be shareholder-unfriendly if not balanced by strong independence and oversight; note policy applies to all NEDs .
- Attendance: No attendance data for Albers in FY2025 (not serving then); board overall met 11 times with ≥75% attendance by FY2025-serving directors—future disclosures should confirm his engagement level .
Overall: Albers brings relevant defense-sector investing and governance expertise, but ACP sponsor rights and his BlueHalo/ACP ties warrant monitoring for conflicts and strong adherence to recusal and independent committee review. Building personal share ownership toward guideline compliance would improve perceived alignment with public shareholders .